Evidence map›Paper›PMID 42152956›Full record

ArticleNeuropsychiatric disease and treatment2026

Shijie Jiang, Zhiguo An, Qiang Hu, Yong Song, Xiaofeng Zhao, Shuaishuai Gao, Qiyu Jia, Bin Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shijie Jiang *Department of Medical Psychology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.
Zhiguo An *Department of Medical Psychology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.
Qiang Hu *Department of Psychiatry, Wuhu Hospital of Anding Hospital, Wuhu, Anhui, People's Republic of China.ORCID 0000-0001-5048-585X
Yong SongScience and Technology Digital Resources and Literature Intelligence Center, Xinjiang Institute of Science and Technology Development Strategy, Urumqi, Xinjiang, People's Republic of China.
Xiaofeng ZhaoXinjiang Science and Technology Project Service Center, Science and Technology Administration of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People's Republic of China.
Shuaishuai GaoDepartment of Medical Psychology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.
Qiyu JiaSchool of Medicine, Nankai University, Tianjin, People's Republic of China.ORCID 0009-0003-7395-7663
Bin XuDepartment of Medical Psychology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aims to elucidate the effects of Methods: By integrating network pharmacology, molecular docking, and animal testing, we systematically revealed the molecular mechanisms of the antidepressant effects of Results: Network pharmacology identified 6 key active components and 74 potential targets, focusing on 25 core targets. Molecular docking demonstrated that key components exhibited high affinity with core targets, with binding energies less than -5 kcal·mol Conclusion:

Indexed as

Cistanche deserticoladepressionmolecular dockingmolecular mechanismsnetwork pharmacologytargets

Identifiers

PMID42152956
PMCPMC13180395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.